Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 65

1.

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.

Moehler M, Gepfner-Tuma I, Maderer A, Thuss-Patience PC, Ruessel J, Hegewisch-Becker S, Wilke H, Al-Batran SE, Rafiyan MR, Weißinger F, Schmoll HJ, Kullmann F, von Weikersthal LF, Siveke JT, Weusmann J, Kanzler S, Schimanski CC, Otte M, Schollenberger L, Koenig J, Galle PR.

BMC Cancer. 2016 Aug 31;16:699. doi: 10.1186/s12885-016-2736-9.

2.

Last line therapy with sorafenib in colorectal cancer: A retrospective analysis.

Martchenko K, Schmidtmann I, Thomaidis T, Thole V, Galle PR, Becker M, Möhler M, Wehler TC, Schimanski CC.

World J Gastroenterol. 2016 Jun 21;22(23):5400-5. doi: 10.3748/wjg.v22.i23.5400.

3.

Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.

Moehler M, Delic M, Goepfert K, Aust D, Grabsch HI, Halama N, Heinrich B, Julie C, Lordick F, Lutz MP, Mauer M, Alsina Maqueda M, Schild H, Schimanski CC, Wagner AD, Roth A, Ducreux M.

Eur J Cancer. 2016 May;59:160-70. doi: 10.1016/j.ejca.2016.02.020. Review.

PMID:
27039171
4.

Analysis of the expression of SDF-1 splicing variants in human colorectal cancer and normal mucosa tissues.

Allami RH, Graf C, Martchenko K, Voss B, Becker M, Berger MR, Galle PR, Theobald M, Wehler TC, Schimanski CC.

Oncol Lett. 2016 Mar;11(3):1873-1878.

5.

Functional diversity of stromal cell-derived factor 1 splice variants in colorectal cancer and melanoma.

Wehler TC, Martchenko K, Allami RH, Becker M, Wehler B, Berger MR, Bals R, Galle PR, Theobald M, Graf C, Schimanski CC.

Int J Colorectal Dis. 2016 Jun;31(6):1225-6. doi: 10.1007/s00384-015-2437-x. No abstract available.

PMID:
26567118
6.

Inclusion of targeted therapies in the standard of care for metastatic colorectal cancer patients in a German cancer center: the more the better?!

Moehler M, Thomaidis T, Zeifri C, Barhoom T, Marquardt J, Ploch P, Schattenberg J, Maderer A, Schimanski CC, Weinmann A, Woerns MA, Kranich AL, Warnecke JM, Galle PR.

J Cancer Res Clin Oncol. 2015 Mar;141(3):515-22. doi: 10.1007/s00432-014-1829-6.

PMID:
25230900
7.

Murine genetic deficiency of neuronal nitric oxide synthase (nNOS(-/-) ) and interstitial cells of Cajal (W/W(v) ): Implications for achalasia?

Müller M, Colcuc S, Drescher DG, Eckardt AJ, von Pein H, Taube C, Schumacher J, Gockel HR, Schimanski CC, Lang H, Gockel I.

J Gastroenterol Hepatol. 2014 Oct;29(10):1800-7. doi: 10.1111/jgh.12600.

PMID:
24720557
8.

Rectal cancer: dynamic contrast-enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression.

Lollert A, Junginger T, Schimanski CC, Biesterfeld S, Gockel I, Düber C, Oberholzer K.

J Magn Reson Imaging. 2014 Jun;39(6):1436-42. doi: 10.1002/jmri.24301.

PMID:
24127411
9.

Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective.

Wehler TC, Graf C, Möhler M, Herzog J, Berger MR, Gockel I, Lang H, Theobald M, Galle PR, Schimanski CC.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1667-72. doi: 10.1007/s00432-013-1483-4. Erratum in: J Cancer Res Clin Oncol. 2013 Nov;139(11):1961-2.

10.

Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients.

Thomaidis T, Weinmann A, Sprinzl M, Kanzler S, Raedle J, Ebert M, Schimanski CC, Galle PR, Hoehler T, Moehler M; Upper-GI-Group of AIO (Arbeitsgemeinschaft Internistische Onkologie), Germany..

Int J Clin Oncol. 2014 Apr;19(2):288-96. doi: 10.1007/s10147-013-0544-7.

PMID:
23532629
11.

Prospective, open, multi-centre phase I/II trial to assess safety and efficacy of neoadjuvant radiochemotherapy with docetaxel and oxaliplatin in patients with adenocarcinoma of the oesophagogastric junction.

Moehler M, Gockel I, Roessler HP, Arnold D, Trarbach T, Thomaidis T, Klautke G, Rödel C, Brenner B, Lang H, Galle PR, Schimanski CC, Schmidberger H.

BMC Cancer. 2013 Feb 11;13:75. doi: 10.1186/1471-2407-13-75.

12.

Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft--no benefit of combination therapy.

Wehler TC, Hamdi S, Maderer A, Graf C, Gockel I, Schmidtmann I, Hainz M, Berger MR, Theobald M, Galle PR, Moehler M, Schimanski CC.

Int J Colorectal Dis. 2013 Mar;28(3):385-98. doi: 10.1007/s00384-012-1551-2.

13.

Preservation of HUGL-1 expression as a favourable prognostic factor in pancreatic carcinoma.

Biesterfeld S, Kauhausen A, Kost C, Gockel I, Schimanski CC, Galle PR.

Anticancer Res. 2012 Aug;32(8):3153-9.

PMID:
22843887
15.

Model of wound healing for esophagogastric anastomoses in rats.

Drescher DG, Vogt J, Gabriel M, Baumgart J, Schimanski CC, Lang H, Gockel I.

Eur Surg Res. 2012;48(4):194-9. doi: 10.1159/000338625.

PMID:
22678054
16.

Selective PI3K inhibition by BKM120 and BEZ235 alone or in combination with chemotherapy in wild-type and mutated human gastrointestinal cancer cell lines.

Mueller A, Bachmann E, Linnig M, Khillimberger K, Schimanski CC, Galle PR, Moehler M.

Cancer Chemother Pharmacol. 2012 Jun;69(6):1601-15. doi: 10.1007/s00280-012-1869-z.

PMID:
22543857
17.

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

Schimanski CC, Möhler M, Schön M, van Cutsem E, Greil R, Bechstein WO, Hegewisch-Becker S, von Wichert G, Vöhringer M, Heike M, Heinemann V, Peeters M, Kanzler S, Kasper S, Overkamp F, Schröder J, Seehofer D, Kullmann F, Linz B, Schmidtmann I, Smith-Machnow V, Gockel I, Lang H, Galle PR.

BMC Cancer. 2012 Apr 11;12:144. doi: 10.1186/1471-2407-12-144.

18.

[With the scalpel against the immune system: HIV infection complicated by an unclear colitis].

Ploch P, Schimanski CC, Goetz M, Orth C, Lang H, Galle PR, Schuchmann M, Kittner JM.

Z Gastroenterol. 2012 Apr;50(4):382-5. doi: 10.1055/s-0031-1273454. German.

PMID:
22467540
19.

Survival after chemotherapy and/or radiotherapy versus self-expanding metal stent insertion in the setting of inoperable esophageal cancer: a case-control study.

Sgourakis G, Gockel I, Karaliotas C, Moehler M, Schimanski CC, Schmidberger H, Junginger T.

BMC Cancer. 2012 Feb 15;12:70. doi: 10.1186/1471-2407-12-70.

20.

Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth.

Menke J, Kriegsmann J, Schimanski CC, Schwartz MM, Schwarting A, Kelley VR.

Cancer Res. 2012 Jan 1;72(1):187-200. doi: 10.1158/0008-5472.CAN-11-1232.

Items per page

Supplemental Content

Loading ...
Support Center